Clinical significance of matrix metalloproteinases activity in acute myocardial infarction
D. P. Papadopoulos1, I. Moyssakis1, T. K. Makris1, M. Poulakou2, G. Stavroulakis1, D. Perrea2, V. E. Votteas1
European Cytokine Network, Vol.16, No.2, pp. 152-160, 2005
Abstract Matrix metalloproteinases (MMP) degrade myocardial fibrillar collagen in acute myocardial
infarction (MI) patients. Their activity is tightly controlled in normal myocardium by a family of closely related
tissue inhibitors known as TIMP. An imbalance in their activity might contribute to post-MI remodeling. Plasma
levels of MMP-1, TIMP-1 and MMP-1/TIMP-1 complex were measured, using relevant ELISA kits, in 24 (22
males-2 females), acute MI patients with a mean age 59 ± 14 years. Blood samples were taken on admission
(0h),and 3h, 6h, 9h, 18h, 24h, 36h, 48h, 3rd, 4th, 5th, 7th, 15th, 30th days after MI. All patients underwent… More >